On the 26th, the MERS coronavirus theme showed a strong performance, rising 3.07% compared to the previous day, while HanAll Biopharma, a related stock drawing attention, surged 8.71% compared to the previous day. HanAll Biopharma is known as an R&D-focused pharmaceutical and bio company.


[Graph] Major stock price changes in the MERS coronavirus theme




According to the analysis by Thinkpool Robo Algorithm RASSI, HanAll Biopharma exceeded the theme's average scores in growth, stability, and profitability, ranking 9th in the quant financial ranking (out of 24 stocks). This can be interpreted as HanAll Biopharma having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.


[Table] Top stocks by financial score within the theme



※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①





한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing